中文         Site Map |
 
 
 
What tools to eliminate Malaria in sub-Sahara Africa?
Date: Aug.21.2013
 
 
 
On 18th July 2013, Guilin Pharma, together with the National Malaria Control Program (NMCP) of Cote d’Ivoire and the Ivorian Society of Infectious and Tropical Disease (ISITD) successfully held a“Malaria Scientific Day”, an academic event on the state of the art and latest evidence-based WHO recommended strategies and field management of malaria in Abidjan, Cote d’Ivoire.
 
The event comprised two important sessions, one in the morning and the other in the evening.The first session in the morning (10-12h), held at the auditorium of the School of Medicine, Abidjan University, focused on new developments in malaria research and was targeted at students, postdoc, scientists and professors. Attendance was high as it attracted more than 150participants. This high-level conference on malaria was animated by two well-known malaria experts, Prof. Ogobara DOUMBO, Director of the Malaria Research and Training Center (MRTC), University of Bamako, Mali and Prof. Umberto D’ALESSANDRO, Team Leader Disease Control & Elimination» at the Medical Research Council Unit in The Gambia. The topics covered were “Malaria in pregnancy” and “The future of infectious diseases and parasitology in the 21st century”.
 
The second event, held in the evening between 6:00p.m and 9:00p.m at the Abidjan International Conference Center, was co-organized by the NMCP (Ministry of Health), the ISITDand by Guilin Pharma; it covered issues related to the management of malaria patients and was targeted at healthcare practitioners. The conference began with an update on antimalarial drug resistance in Sub-Saharan Africa by Dr Louis PENALI regional Director of wWARN, UCAD, Senegal,and continued with an intervention by Prof. Umberto D’ALESSANDRO on antimalarial treatments. Subsequently, Prof. Ogobara K. DOUMBO presented the possible impact of seasonal malaria chemoprevention (SMC) with amodiaquine and sulfadoxine-pyrimethamine in West African countries. The session was concluded by Dr. Méa Antoine TANOH, the Director of the NMCP who presented the new Ivorian national malaria control policy and guidelines, including the use of parenteral artesunate for severe malaria cases. The event was attended by about 300 local healthcare practitioners, doctors, nurses and members of the ISITD who animated a lively discussion at the end of the presentations.
 
The “Malaria Scientific Day” was an innovative approach of pharmaceutical marketing in whichgovernment authorities and Guilin Pharma worked together for a successful scientific event thatalso helped to consolidate the professional image of Guilin Pharma as “the expert of Malaria”.Considering the positive experience and feedback received, Guilin Pharma will continue to hold the“Malaria Scientific Day” in other major African markets, with the aim of building an academic communication platform between world-famous malaria experts and local healthcare practitioners, and so improving the local skills to contribute in the fight against malaria in Africa. 
 

This site is published by Guilin Pharmaceutical (Shanghai) Corporation,        which is solely responsible for its content. All rights reserved.

© Guilin Pharmaceutical (Shanghai) Co., Ltd. 2017.

青海快3开奖结果今期 哈灵浙江本地麻将 秒速飞艇开奖软件 11选五5开奖结果 国标麻将理论最大番数 股市热点软件分析 白小姐六肖选一肖中特139期 上海明星麻将到底有没有挂 大地棋牌游戏注册网址 北京幸运28*结果 云南11选5开奖结 福建36选7开奖规则 快3 1.5.0腾讯广东麻将 加拿大快乐8晚上几点开奖 原油开户如何配资 十大最赚钱的游戏排行